powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1356634612
Mahshid Mohseni
MD
Endocrinology
Saint Louis,
MO
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
QUALITY · MIPS · 2024
Final MIPS score
84.2
Quality
71.6
Cost
75.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.39%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
760
Beneficiaries
—
Total drug cost
$655K
Distinct drugs
9
Brand share
31.8%
Top prescribed drugs
Alendronate Sodium
390 claims
Teriparatide
79 claims
Abaloparatide
64 claims
Ergocalciferol (Vitamin D2)
54 claims
Levothyroxine Sodium
50 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
3,190
Unique beneficiaries
—
Total services
62,946
Distinct HCPCS
10
Medicare payment
$1.0M
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 144 Endocrinology providers in MO — top quintile (cohort median 929).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$150
Payment records
2
By payment type
Food and Beverage
$150
Top paying entities
Food and Beverage
$150